John Didsbury

Current

• Consultant at DARA BioSciences, Inc.

Past

• President & COO / CSO at DARA BioSciences, Inc.
• CEO at Nuada Pharmaceuticals
• Head of Strategy and Operations at GlaxoSmithKline

• Assistan Professor at Duke University Medical Center

see less...

1 more...

Education

• University of Vermont College of Medicine
• The University of Connecticut

Connections

70 connections

Industry

Pharmaceuticals

John Didsbury’s Summary

President and COO / CSO, DARA BioSciences, Inc (NASDAQ:CM - DARA); 2005 - 2009

CEO Nuada Pharmaceuticals; 2002 - 2005

Head of Strategy and Operations, GSK, Inc. 1995-2002

John Didsbury’s Specialties:

Highly-qualified Executive Manager with over 22 years of experience within the pharmaceutical and biotechnology industries in both small and large public and private companies. Background and knowledge in both Science and Business applied to the analysis, selection and development of optimal drug candidate opportunities. Ability to derive maximum output from staff and effectively adapt operations to market conditions.

John Didsbury’s Experience

• Consultant

  DARA BioSciences, Inc.

  (Pharmaceuticals industry)

  February 2009 — Present (6 months)

• President & COO / CSO

  DARA BioSciences, Inc.

  (Pharmaceuticals industry)

  November 2005 — February 2009 (3 years 4 months)

• CEO

  Nuada Pharmaceuticals

  (Pharmaceuticals industry)

  2002 — 2005 (3 years)

• Head of Strategy and Operations

  GlaxoSmithKline

  (Public Company; GSK; Pharmaceuticals industry)

  June 1995 — May 2002 (7 years)

• Assistan Professor

  Duke University Medical Center

  (Pharmaceuticals industry)

  1989 — 1992 (3 years)

John Didsbury’s Education

• University of Vermont College of Medicine

  Ph.D. , Medical Microbiology , 1977 — 1982

• The University of Connecticut

  B.A. , Biology, Chemistry , 1973 — 1977

John Didsbury’s Contact Settings

Interested In:

• career opportunities
• new ventures
• job inquiries
• expertise requests
• business deals
• reference requests
• getting back in touch